Phenotype of TP53 and influence on outcome after allogeneic stem cell transplantation for myelofibrosis

被引：0
|
作者：
Gagelmann, N. [1 ]
Badbaran, A. [1 ]
Panagiota, V [2 ]
Thol, F. [2 ]
Heuser, M. [2 ]
Wolschke, C. [1 ]
Schroeder, T. [3 ]
Rautenberg, C. [3 ]
Reinhardt, H. C. [3 ]
Cassinat, B. [4 ]
Robin, M. [4 ]
Scott, B. L. [5 ]
Kroeger, N. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[2] Hannover Med Sch, Hannover, Germany
[3] Univ Klinikum Essen, Essen, Germany
[4] Hop St Louis, APHP, Paris, France
[5] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V295
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] TP53 mutation in allogeneic hematopoietic cell transplantation for de novo myelodysplastic syndrome
    Kim, Yoo-Jin
    Jung, Seung-Hyun
    Hur, Eun-Hye
    Choi, Eun-Ji
    Lee, Kyoo-Hyung
    Yim, Seon-Hee
    Kim, Hye-Jung
    Kwon, Yong-Rim
    Jeon, Young-Woo
    Lee, Sug Hyung
    Chung, Yeun-Jun
    Lee, Je-Hwan
    BONE MARROW TRANSPLANTATION, 2018, 53 : 667 - 668
  • [22] IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY
    Diez Campelo, M.
    Caballero, J. C.
    Sanchez Barba, M.
    Del Rey, M.
    Janusz, K.
    Lumbreras, E.
    Abaigar, M.
    Robledo, C.
    Jerez, A.
    Calderon-Cabrera, C.
    Such, E.
    Cervera, J.
    Sanz, G.
    Valcarcel, D.
    Hernandez-Rivas, J. M.
    Del Canizo, C.
    LEUKEMIA RESEARCH, 2015, 39 : S102 - S103
  • [23] Impact of TP53 Allelic State on Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasm
    Jiang, Bingqian
    Yang, Tingting
    Luo, Yi
    Zhao, Yanmin
    Ouyang, Guifang
    Yu, Jian
    Lan, Jianping
    Lu, Ying
    Lai, Xiaoyu
    Ye, Baodong
    Chen, Yi
    Liu, Lizhen
    Xu, Yang
    Shi, Pengfei
    Xiao, Haowen
    Hu, Huixian
    Guo, Qunyi
    Fu, Huarui
    Ye, Yishan
    Wang, Xinyu
    Sun, Jie
    Zheng, Weiyan
    He, Jingsong
    Zhao, Yi
    Wu, Wenjun
    Cai, Zhen
    Wei, Guoqing
    Huang, He
    Shi, Jimin
    BLOOD, 2023, 142
  • [24] Presence of TP53 Mutation and Monosomal Karyotype Predict the Outcome of Patients with Acute Myeloid Leukemia in Non-Remission at Allogeneic Stem Cell Transplantation
    Najima, Yuho
    Sadato, Daichi
    Harada, Yuka
    Hirama, Chizuko
    Oboki, Keisuke
    Toya, Takashi
    Doki, Noriko
    Haraguchi, Kyoko
    Yoshifuji, Kota
    Akiyama, Megumi
    Inamoto, Kyoko
    Igarashi, Aiko
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Okuyama, Yoshiki
    Sakamaki, Hisashi
    Harada, Hironori
    Ohashi, Kazuteru
    BLOOD, 2018, 132
  • [25] Allogeneic stem-cell transplantation for myelofibrosis
    Lavi, Noa
    Rowe, Jacob M.
    Zuckerman, Tsila
    CURRENT OPINION IN HEMATOLOGY, 2017, 24 (06) : 475 - 480
  • [26] Allogeneic hematopoletic stem cell transplantation for myelofibrosis
    Rondelli, Damiano
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (10): : 1449 - 1452
  • [27] Importance of allogeneic stem cell transplantation in myelofibrosis
    Hirschbuehl, Klaus
    Schmid, Christoph
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (03) : 215 - 219
  • [28] Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis
    Popat, Uday
    Rondon, Gabriela
    Alousi, Amin
    Anderlini, Paolo
    Andersson, Borje
    Hosing, Chitra
    de Lima, Marcos
    Ciurea, Stefan
    Giralt, Sergio
    Kebriaei, Partow
    Nieto, Yago
    Khouri, Issa
    Qazilbash, Muzaffar H.
    Jones, Roy
    Champlin, Richard
    BLOOD, 2009, 114 (22) : 900 - 900
  • [29] ALLOGENEIC STEM CELL TRANSPLANTATION FOR PRIMARY MYELOFIBROSIS
    Zavrelova, A.
    Miriam, L.
    Radocha, J.
    Belohlavkova, P.
    Zak, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S141 - S141
  • [30] Allogeneic stem cell transplantation as treatment for myelofibrosis
    Papageorgiou, S. G.
    Castleton, A.
    Bloor, A.
    Kottaridis, P. D.
    BONE MARROW TRANSPLANTATION, 2006, 38 (11) : 721 - 727
12345